Non classé

Launch of the second call for projects “Pain & Animal Health”

As the first research foundation in the field of pain, the ANALGESIA Institute is launching, for the 2nd consecutive year, the call for STARTER projects “Pain & Animal Health” granting €18,000, thanks to the renewed support of the Domes Pharma Group.

The field of pain has remained on the margins of the great medical advances of the last 50 years. To meet this major challenge, the ANALGESIA Institute has applied itself to reviving innovation in this field by relying on the One Health concept: a single health for humans and animals. By bringing doctors and veterinarians together, this approach proposes a new R&D model that is inspired by the patient, whether it’s human or animal, to finally offer new treatments that will benefit both humans and animals.

A long-standing player in the veterinary pharmaceutical industry in France, the Domes Pharma Group has put the quality of the relationship between humans and animals at the heart of its vision. By partnering with the ANALGESIA Institute, the Group’s objective is to ensure that the knowledge, consideration and treatment of animal pain, (the existence of which has only been truly accepted since the 1980s) can also benefit from the latest research advances.

The Domes Pharma Group’s commitment, to the ANALGESIA Institute, is formalized  by the renewal of the “ANALGESIA – Domes Pharma Pain and Animal Health” award, which will be granted on the basis of a call for projects.

This important support allows the ANALGESIA Institute to commit even further to innovation in pain management for the benefit of the veterinary world over the long term. 

For this 2nd edition, the ANALGESIA Institute will grant  funding of 18,000 euros. This amount is intended to help an academic team wishing to develop a research theme on pain in animal health to acquire or complete preliminary results that will then allow it to apply for competitive calls for projects (national grant, H2020…). In 2019, the prize was awarded to a Franco-Brazilian study project that evaluated different physiotherapy methods for the immediate relief of myofascial pain in dogs.

The call for projects is open to all academic teams (French or not), who conduct research in this field.


  • Launch of the call of projects: April 20, 2020
  • Deadline for sending applications: June 26, 2020 at noon      
  • Award ceremony: Autumn 2020       

How to apply?

Download the application form on the ANALGESIA Institute website

 Any questions?

Do not hesitate to contact the ANALGESIA Institute at the following email address:

Download Press release

The Dômes Pharma Group annouces the creation of its Foundation dedicated to Animal Assisted Therapy

To demonstrate that its strapline Linked by Nature is backed up with real actions and to pay tribute to the passion and values of its founders, the Dômes Pharma Group announces the creation of its Corporate Foundation dedicated to Animal Assisted Therapies. Its mission is to support projects that enable the most vulnerable people to share a moment of complicity, relaxation or care with an animal to benefit from the deep and lasting benefits of this relationship. An important step in the Dômes Pharma Group’s CSR approach and social commitment.

The first project upholded by the Dômes Pharma Foundation aims to study the effect of equitherapy on the quality of life of women diagnosed with breast cancer. This random clinical trial has been conducted on 86 women over 4 years by the Equiphoria Institute, the Centre de Cancérologie du Grand Montpellier and the Association Montpellier Institut du Sein (MIS). Breast cancer is the most common type of cancer and the third leading cause of death among women. Rehabilitation management is essential during the period of remission,  especially to limit the risk of recurrence.

Horses are very helpful in the field of healthcare no matter what the problem caused by the disease. On a psychological level, they are able to perceive, respond and learn from the feelings they can sense through minimal sensory stimuli; thus they guide the therapist and the patient on the path to reconstruction. On a physical level, the movement of the horse and the interaction with the patient, allows reinforcement of the functional capabilities.

Pascale, in the photo with the horse “Winner” for the Group’s New Year’s card, is one of the participants of the program. She shared with us her testimony on the benefits of this therapy:

“I had no idea how much work and contact with a horse could transform so profoundly.
Only three sessions were enough to give me  my smile back, my self-confidence and my life. Because with a horse you are not in the mind, you can’t tell him stories and neither can he.
The horse projects us into reality and sends us back an image of ourselves from which we cannot escape because it is an evidence, we are in the feeling.
Thanks to the multidisciplinary team that provides support, tools and encouragement, we emerge transformed from such an experience. For me it’s a rebirth! ” Pascale M.

Witnessing the unique bond between Humans and Animals for over 70 years, the Dômes Pharma Group is proud of this new step in its social commitment. The Foundation will make it possible to ensure that its activities are sustainable and have a real impact on beneficiaries. Three experts in animal mediation and adapted sports have agreed to sit on the Foundation’s board. They are Yasmine Debarge (CANIDEA), Hélène Viruega (EQUIPHORIA) and Sonia Wittreck (Veterinarian of the Disabled Sports Federation). They will assist the Foundation in the choice of projects to be supported by ensuring that they bring benefits to Humans while respecting the well-being of the Animal.


Arrival of a soft chew range for animal health medicines and food supplements

EUROPHARTECH selected the CPhI 2018 in Madrid to inform customers and partners of the imminent arrival of a ‘soft chew’ range, designed for the production of animal health medicines and food supplements. EUROPHARTECH is aware that compliance with treatment is a critical point for the support of a sick animal and has already acquired solid experience in the development of palatable food supplements and medicines.

With this new investment of nearly 2M€ – which will be fully operational by year-end – EUROPHARTECH intends to develop a real specialty that will be proposed as full service, from formulation to the finished product. Soft Chew samples and applications will be presented at the CPhI Madrid (October ç-11) on stand 3F73.

This galenic form is characterized by a high percentage of palatable agents facilitating mono-dose treatments but also improving the observance of long-term treatments, making it popular with veterinarians and pet owners.

This galenic form is not more prevalent in animal health today due to the difficulty of producing homogeneous dosage forms by extrusion. To avoid this problem, Europhartech opted for specific compression technology that allows for optimum control of the active principle unit mass and therefore the quantity of active principle contained in each unit produced. The palatable rate implemented in this technology can even mask certain active components that our four-legged companions do not appreciate. Diverse formulations can produce both medication (antibiotics, anti-parasitic, neurological…) and food supplements (vitamins, minerals, plant extracts…).